Search - tctmd.com

Displaying 1 - 20 of 57

Sort: Relevancy | Date

Presentation THT 2026

Cardiogenic Shock Working Group: Triumphs and Tribulations

Presenter: Rachna Kataria

March 04, 2026

Presentation THT 2026

The PleioFlow Transcather Valve-powered Flow Pump - Next-Generation ultra-low profile physiologic circulatory support for patients in early stage Cardiogenic Shock

Presenter: Theo Mastrokostopoulos

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

Presenter: Sriram Nathan

March 04, 2026

Presentation THT 2026

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Presenter: Beth A. Davison

March 04, 2026

Presentation THT 2026

When One Cause Isn't Enough: A Case of Cardiogenic Shock from Multiple Pathologies

Presenter: Archanna Radakrishnan

March 04, 2026

Presentation THT 2026

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Presenter: David Israeli

March 03, 2026

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Presenter: Ronit Kar

March 03, 2026

Presentation THT 2026

Prognostic Utility of Serum Lactate Dynamics for In-Hospital Mortality in Cardiogenic Shock: A Single Hub Regional Center Analysis

Presenter: Raul R. Neri Bale

March 03, 2026

Presentation THT 2026

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

Contemporary Use of Intra-aortic Balloon Pump in Heart Failure Cardiogenic Shock

Presenter: Naa'irah N. Muhammad

March 03, 2026

Presentation THT 2026

Extra-Cardiac Compression for Severe Cardiogenic Shock

Presenter: Mitchell W. Krucoff

March 03, 2026

Presentation THT 2026

Devices Are Not Enough: Revitalizing Development of New Drugs for Cardiogenic Shock

Presenter: Alexandre Mebazaa

March 03, 2026

Presentation THT 2026

CSWG/AHA/C3TN: What Have We Learned From These Real World Registries

Presenter: Shashank Shekhar Sinha

March 03, 2026

Presentation THT 2026

The Special Cases of In- and Out-of Hospital Cardiac Arrest

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Enhancing Risk Prediction With Novel Approaches To Define Cardiogenic Shock Phenotypes

Presenter: Jonas Sundermeyer

March 03, 2026

Presentation THT 2026

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Presenter: David A. Baran

March 03, 2026

Advertisement

Cardiogenic Shock Working Group: Triumphs and Tribulations

The PleioFlow Transcather Valve-powered Flow Pump - Next-Generation ultra-low profile physiologic circulatory support for patients in early stage Cardiogenic Shock

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

When One Cause Isn't Enough: A Case of Cardiogenic Shock from Multiple Pathologies

First-in-Human Use of the Elevate™ Percutaneous Left Ventricular Assist Device in Cardiogenic Shock

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Comorbidity Burden and 30-Day Readmission After Cardiogenic Shock: Predictive Limits of Established Indices

Prognostic Utility of Serum Lactate Dynamics for In-Hospital Mortality in Cardiogenic Shock: A Single Hub Regional Center Analysis

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Contemporary Use of Intra-aortic Balloon Pump in Heart Failure Cardiogenic Shock

Extra-Cardiac Compression for Severe Cardiogenic Shock

Devices Are Not Enough: Revitalizing Development of New Drugs for Cardiogenic Shock

CSWG/AHA/C3TN: What Have We Learned From These Real World Registries

The Special Cases of In- and Out-of Hospital Cardiac Arrest

Enhancing Risk Prediction With Novel Approaches To Define Cardiogenic Shock Phenotypes

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content